The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia's Social Health Insurance System

Value Health Reg Issues. 2020 May:21:1-8. doi: 10.1016/j.vhri.2019.05.005. Epub 2019 Oct 18.

Abstract

Background: Indonesia's social health insurance (Jaminan Kesehatan Nasional, JKN) has been implemented since 2014. To support medicine provision, the government launched policies reform on medicine pricing, procurement and reimbursement; hence, the system might affect medicine prices in the country.

Objective: To evaluate the effects of the pharmaceutical policies reforms on medicine procurement prices.

Methods: This was a pre-post observational study. Medicine price data were collected retrospectively from the 2013 Ministry of Health procurement price list, the 2017 e-catalogue procurement system, and the procurement departments at 2 hospitals in Jakarta and Cilegon (both categorized as region I). The 2013 national procurement price was compared with the 2017 e-catalogue price. The hospitals' procurement prices were collected from the data 3 years before and 3 years under Indonesia's social health insurance JKN (2011-2016), and the data were used to assess the medicine procurement prices in real conditions. The outcome measure was the difference in procurement prices before and under the JKN.

Results: The results showed that the procurement prices of 429 (79.6%) of 539 medicines listed in the 2017 e-catalogue decreased, of which 210 items (39.0%) showed over a 50% decrease. Nevertheless, the procurement prices of 104 items (19.3%) increased, especially those that were still under patent or those with a few brands registered in Indonesia. The procurement prices in public and private hospitals showed a similar trend, that is, a significant decrease. Interestingly, non-e-catalogue medicine prices also decreased quite steeply, although the prices of the branded generic category in the private hospital remained unchanged.

Conclusion: The pharmaceutical policies under the JKN implementation had a profound impact on decreasing medicine procurement prices in Indonesia.

Keywords: Indonesia’s social health insurance; e-catalogue; medicine price; procurement.

Publication types

  • Observational Study

MeSH terms

  • Drug Costs / standards*
  • Drug Costs / statistics & numerical data
  • Health Policy*
  • Humans
  • Indonesia
  • Medication Systems / economics*
  • Medication Systems / statistics & numerical data
  • National Health Programs / economics*
  • National Health Programs / statistics & numerical data
  • Retrospective Studies